Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5866 AL 5880

Naturally occurring autoantibodies against β-Amyloid

Bach JP, Dodel R.

Adv Exp Med Biol. 2012;750:91-9. doi: 10.1007/978-1-4614-3461-0_7.

[Gamma-secretase inhibitors in Alzheimer's disease therapy]

Katarína S, Jan K, Kamil K, Kamil M.

Ceska Slov Farm. 2012 Jun;61(3):93-100.

Targeting synaptic dysfunction in Alzheimer's disease therapy

Nisticò R, Pignatelli M, Piccinin S, Mercuri NB, Collingridge G.

Mol Neurobiol. 2012 Dec;46(3):572-87. doi: 10.1007/s12035-012-8324-3. Epub 2012 Aug 23.

The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study

Padala KP, Padala PR, McNeilly DP, Geske JA, Sullivan DH, Potter JF.

Am J Geriatr Pharmacother. 2012 Oct;10(5):296-302. doi: 10.1016/j.amjopharm.2012.08.002. Epub 2012 Aug 22.

Natural products as a rich source of tau-targeting drugs for Alzheimer's disease

Calcul L, Zhang B, Jinwal UK, Dickey CA, Baker BJ.

Future Med Chem. 2012 Sep;4(13):1751-61. doi: 10.4155/fmc.12.124.

BACE1 in Alzheimer's disease

Sathya M, Premkumar P, Karthick C, Moorthi P, Jayachandran KS, Anusuyadevi M.

Clin Chim Acta. 2012 Dec 24;414:171-8. doi: 10.1016/j.cca.2012.08.013. Epub 2012 Aug 20.

Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease

Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J.

Am J Alzheimers Dis Other Demen. 2012 Sep;27(6):421-32. doi: 10.1177/1533317512454708.

The immunopathogenic role of reactive oxygen species in Alzheimer disease

Mohsenzadegan M, Mirshafiey A.

Iran J Allergy Asthma Immunol. 2012 Sep;11(3):203-16.

Treatment strategies targeting amyloid β-protein

Schenk D, Basi GS, Pangalos MN.

Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a006387. doi: 10.1101/cshperspect.a006387.

Effect of some medicinal plant extracts on the oxidative stress status in Alzheimer's disease induced in rats

Mahdy K, Shaker O, Wafay H, Nassar Y, Hassan H, Hussein A.

Eur Rev Med Pharmacol Sci. 2012 Jul;16 Suppl 3:31-42.

The potential protective effect of tramiprosate (homotaurine) against Alzheimer's disease: a review

Caltagirone C, Ferrannini L, Marchionni N, Nappi G, Scapagnini G, Trabucchi M.

Aging Clin Exp Res. 2012 Dec;24(6):580-7. doi: 10.3275/8585. Epub 2012 Sep 5.

Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain

Raukas M, Rebane R, Mahlapuu R, Jefremov V, Zilmer K, Karelson E, Bogdanovic N, Zilmer M.

Free Radic Res. 2012 Dec;46(12):1490-5. doi: 10.3109/10715762.2012.728286. Epub 2012 Sep 27.

Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease

Li C, Ebrahimi A, Schluesener H.

Ageing Res Rev. 2013 Jan;12(1):116-40. doi: 10.1016/j.arr.2012.09.002. Epub 2012 Sep 12.

The future dominance of combination therapies: implications for today's medical research

de Grey AD.

Rejuvenation Res. 2012 Oct;15(5):443-4. doi: 10.1089/rej.2012.1376.

Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Reddy PH.

Biochim Biophys Acta. 2013 Jan;1832(1):67-75. doi: 10.1016/j.bbadis.2012.09.003. Epub 2012 Sep 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias